secwatch.observer — SEC 8-K summary
======================================

Issuer:     FUSE GROUP HOLDING INC. (FUST)
CIK:        0001636051
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001185185-21-001433
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 1.02, 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fuse Group terminates E-Mo Biotech acquisition; restates Q1, Q2 2021 financials
-------------------------------------------------------------------------------

- Terminated Share Exchange Agreement to acquire E-Mo Biotech; no shares issued or exchanged.
- Will restate financials for quarters ended March 31 and June 30, 2021 due to reclassification error.
- 14,285,715 shares issued as prepayment for mining rights reclassified to equity deduction per SAB Topic 4:E.
- Non-reliance on previously issued Q1 and Q2 2021 financial statements; amendment to 10-Qs planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/0001185185-21-001433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/fuseent20211001_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-21-001433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer